In the US, Cytosar-U is a member of the drug class antimetabolites and is used to treat Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia, Meningeal Leukemia and Non-Hodgkin's Lymphoma.
Ingredient matches for Cytosar-U
Cytarabine is reported as an ingredient of Cytosar-U in the following countries:
- South Korea
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.